INVESTOR ALERT: Investigation of MabVax Therapeutics Announced by Holzer & Holzer

ATLANTA--(BUSINESS WIRE)-- Holzer & Holzer, LLC is investigating whether MabVax Therapeutics Holdings, Inc. (“MabVax” or the “Company”) (NASDAQ: MBVX) complied with the federal securities laws. On January 30, 2018, MabVax announced that it received notice that the Securities and Exchange Commission (“SEC”) is investigating and examining certain of the Company’s filed registration statements and subsequent amendments. The price of MabVax stock fell significantly following the announcement. If you purchased MabVax common stock ...

EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against MabVax Therapeutics Holdings, Inc. – MBVX

NEW YORK--(BUSINESS WIRE)-- Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of purchasers of the securities of MabVax Therapeutics Holdings, Inc. (NASDAQ: MBVX) resulting from allegations that MabVax may have issued materially misleading business information to the investing public. On January 30, 2018, MabVax announced “that it received notice that the Securities and Exchange Commission (“SEC”) was conducting an investigation and examination pursuant to S...

Daily Insider Ratings Report: Jan 24, 2018

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

PBSV: Steady as she goes

BCLI: KOL Event Gives Overview of the use of NurOwn® in Alzheimer’s Disease; Raising Valuation to $25/Share...

MNOV: FDA Gives OK to Initiate Clinical Trial of MN-166 to Prevent ARDS in COVID- 19 Patients...